T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rivian
RIVN
|
+$18.7B |
| 2 |
Apple
AAPL
|
+$5.48B |
| 3 |
NVIDIA
NVDA
|
+$5.33B |
| 4 |
Tesla
TSLA
|
+$4.47B |
| 5 |
Microsoft
MSFT
|
+$2.15B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$4.26B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.3B |
| 3 |
Morgan Stanley
MS
|
+$2.82B |
| 4 |
Global Payments
GPN
|
+$2.43B |
| 5 |
PayPal
PYPL
|
+$2B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.36% |
| 2 | Healthcare | 16.09% |
| 3 | Consumer Discretionary | 15.79% |
| 4 | Communication Services | 12.38% |
| 5 | Financials | 10.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Diodes
DIOD
$4.48B
| $57.6M | 0.01% |
524,649
+616
| +0.1% | +$62.5K |
|
952
ADC Therapeutics
ADCT
$134M
| $57.6M | 0.01% |
2,851,437
+22,697
| +0.8% | +$547K |
|
953
Invesco
IVZ
$14.3B
| $57.6M | 0.01% |
2,500,974
+1,300,656
| +108% | +$31.7M |
|
|
TCN
954
DELISTED
Tricon Residential Inc.
TCN
| $57.4M | 0.01% |
+3,753,389
| New | +$53.4M |
|
955
Archer Daniels Midland
ADM
$38.6B
| $57.3M | 0.01% |
848,330
-30,844
| -4% | -$1.99M |
|
956
Host Hotels & Resorts
HST
$15.6B
| $57.1M | 0.01% |
3,281,641
+433,389
| +15% | +$7.31M |
|
|
WBA
957
DELISTED
Walgreens Boots Alliance
WBA
| $56.9M | 0.01% |
1,091,054
-40,808
| -4% | -$1.98M |
|
958
Eastern Bankshares
EBC
$5.37B
| $56.5M | 0.01% |
2,801,436
-46,256
| -2% | -$960K |
|
959
dLocal
DLO
$4.34B
| $56.4M | 0.01% |
1,579,075
+151,262
| +11% | +$6.54M |
|
|
HAYN
960
DELISTED
Haynes International, Inc.
HAYN
| $56.2M | 0.01% |
1,392,727
-56,123
| -4% | -$2.28M |
|
|
SNCY
961
DELISTED
Sun Country Airlines
SNCY
| $56.2M | 0.01% |
2,061,002
+455,630
| +28% | +$13.6M |
|
962
Tenaya Therapeutics
TNYA
$164M
| $55.6M | 0.01% |
2,993,503
+220,394
| +8% | +$4.8M |
|
963
Bio-Rad Laboratories Class A
BIO
$9.66B
| $55.5M | 0.01% |
73,457
-749
| -1% | -$561K |
|
964
Madison Square Garden
MSGS
$9.94B
| $55.4M | 0.01% |
319,117
+46,923
| +17% | +$8.52M |
|
|
PLAN
965
DELISTED
Anaplan, Inc.
PLAN
| $55.4M | 0.01% |
1,208,686
-108,618
| -8% | -$5.99M |
|
966
Dutch Bros
BROS
$8.93B
| $55.3M | 0.01% |
1,086,856
-369,914
| -25% | -$20.5M |
|
967
Lennar Class A
LEN
$21.1B
| $55.3M | 0.01% |
491,618
-16,619
| -3% | -$1.7M |
|
|
HIBB
968
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $55.2M | 0.01% |
767,723
-15,780
| -2% | -$1.26M |
|
969
Asbury Automotive
ABG
$3.78B
| $55.1M | 0.01% |
319,254
-19,611
| -6% | -$3.61M |
|
|
BOAC.U
970
DELISTED
Bluescape Opportunities Acquisition Corp. Units, each consisting of one Class A ordinary share, and one-half of one redeemable warrant
BOAC.U
| $55.1M | 0.01% |
5,426,055
-115,110
| -2% | -$1.18M |
|
|
SLGC
971
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $54.9M | ﹤0.01% |
4,718,721
+2,903,722
| +160% | +$34.8M |
|
972
REX American Resources
REX
$1.44B
| $54.9M | ﹤0.01% |
3,428,832
-227,052
| -6% | -$3.47M |
|
973
Wendy's
WEN
$1.65B
| $54.8M | ﹤0.01% |
2,298,551
-72,223
| -3% | -$1.61M |
|
974
CBRE Group
CBRE
$44B
| $54.7M | ﹤0.01% |
504,110
-19,437
| -4% | -$1.99M |
|
|
CDR
975
DELISTED
Cedar Realty Trust, Inc
CDR
| $54.6M | ﹤0.01% |
2,174,989
-71,929
| -3% | -$1.62M |
|
Similar funds
T. Rowe Price Associates's Q4 2021 Portfolio in Review
As of Q4 2021, T. Rowe Price Associates held 3,121 positions worth $1.11T, up 4.6% from $1.06T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q4 2021 filing shows 186 new, 817 increased, 1,825 reduced and 148 closed positions. Its largest new stake was Rivian: 162,080,423 shares worth $16.1B. The largest sale was Visa, an estimated $4.26B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2021 buy was Rivian: 162,080,423 shares worth $16.1B.
- T. Rowe Price Associates added most to Apple in Q4 2021, an estimated $5.48B increase.
- T. Rowe Price Associates's biggest Q4 2021 reduction was Visa, cutting an estimated $4.26B.
- T. Rowe Price Associates fully exited Acceleron Pharma in Q4 2021, selling an estimated $923M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $1.11T portfolio in Q4 2021.
- T. Rowe Price Associates opened 186 new positions and closed 148 in Q4 2021.
- T. Rowe Price Associates's portfolio value rose 4.6% quarter-over-quarter to $1.11T.
Based on T. Rowe Price Associates's 13F filing for Q4 2021, filed 14 Feb 2022.